Spine Wave Announces FDA Clearance of the StaXx® XDL Expandable Device
August 29, 2011

NORCAL Mutual Acquires Medicus Insurance Company
July 29, 2011

Still River Systems Sign Patent License Agreement With the Massachusetts Institute of Technology
Jun 22, 2011

VaxInnate Awarded Contract by the U.S. Government To Develop Recombinant Seasonal and Pandemic Flu Vaccines
March 01, 2011

GSK and Amicus Therapeutics Enter Exclusive Worldwide Agreement to Develop and Commercialize Amigal™ for Fabry Disease
October 29, 2010

BioRelix Enters Antibacterial Collaboration with Merck
October 4, 2010

OpGen Completes $17 Million Series B Financing
September 27, 2010

Twelve-Week MiDAS I Clinical Study Data Confirm Safety, Efficacy of Vertos Medical's mild®
July 19, 2010

Medicus receives approval to insure Alabama physicians
July 19, 2010

Industry Veteran Douglas White Appointed Chief Executive Officer of OpGen
June 30, 2010

Gilead Sciences to Acquire CGI Pharmaceuticals for up to $120 Million
June 25, 2010

OpGen Launches Argus Optical Mapping System for Automated, Microbial Whole Genome Analysis
June 9, 2010

VaxInnate’s VAX125 Seasonal Flu Vaccine Shown Safe and Highly Immunogenic in Phase II Study of Elderly Subjects
April 27, 2010

Sandoz to acquire Oriel Therapeutics, gaining rights to portfolio of respiratory products targeting asthma and COPD
April 19, 2010

PrimeraDx Announces the Expansion of its Senior Management Team
March 22, 2010

Dr. Thomas Hofstaetter Named President and CEO of VaxInnate
March 18, 2010

Valeritas Announces Appointment of New CFO
March 17, 2010

Medicus Insurance Company Offers New Policy Endorsement
March 16, 2010

Resolvyx and Collaborators Publish Study Showing Potential of Neuroprotectin D1 (NPD1) To Treat Neovascular Eye Disease
March 12, 2010

Vertos Medical's Prospective Outcomes Study Demonstrates Efficacy, Validates Safety Profile of mild®
March 12, 2010

Amicus Therapeutics Announces Closing of $18.5 Million Registered Direct Offering of Common Stock
March 2, 2010

Acute Study Demonstrates Safety of Vertos Medical's mild® Procedure; Findings Appear in Pain Physician Journal
February 24, 2010

Amicus Therapeutics Presents Positive Data Update From Phase 2 Extension Study of Amigal™ for Fabry Disease
February 11, 2010

CMT and Ameritox Announce Partnership to Combat Opioid Overuse
February 1, 2010

Vertos Medical Completes Enrollment in U.S. IRB I Study of mild®
January 21, 2010

CMT and Gateway Health Plan to Present Medical Management Strategies for Behavioral Healthcare Patients in Special Needs Plans
January 20, 2010

VaxInnate licenses recombinant H1N1 Pandemic Swine Flu vaccine to Biological E.
January 12, 2010